Back to Search Start Over

Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial.

Authors :
Mastroianni, Riccardo
Ferriero, Mariaconsiglia
Tuderti, Gabriele
Anceschi, Umberto
Bove, Alfredo Maria
Brassetti, Aldo
Misuraca, Leonardo
Zampa, Ashanti
Torregiani, Giulia
Ghiani, Edoardo
Giannarelli, Diana
Guaglianone, Salvatore
Gallucci, Michele
Simone, Giuseppe
Source :
Journal of Urology; May2022, Vol. 207 Issue 5, p983-992, 11p
Publication Year :
2022

Abstract

Purpose: Radical cystectomy (RC) with urinary diversion (UD) is still considered a complex surgery associated with significant morbidity. Open RC (ORC) remains the reference option of treatment, even if adoption of robot-assisted RC (RARC) is rapidly increasing. To date, all the available randomized controlled trials were characterized by an extracorporeal approach in performing UD, undermining potential benefits of a totally minimally invasive procedure. In this study, we aimed to report perioperative and 6-month outcomes from the first RCT comparing ORC and RARC with totally intracorporeal UD. Materials and Methods: Patients were eligible for randomization if they had a diagnostic transurethral resection of bladder tumor with cT2-4, cN0, cM0 or recurrent high-grade nonmuscle-invasive bladder cancer and no anesthesiological contraindications to robotic surgery. Patients were enrolled with a covariate adaptive randomization process based on the following variables: body mass index, American Society of Anesthesiologists-score, baseline hemoglobin, planned UD, neoadjuvant chemotherapy and cT stage. The primary end point was to demonstrate the superiority of RARC with intracorporeal UD in terms of a 50% transfusion rate reduction. Results: Overall, 116 consecutive patients (58 RARC, 58 ORC) were enrolled. Among primary endpoint, overall perioperative transfusion rates were significantly lower in the RARC cohort (RARC: 22% vs ORC: 41%; p[0.046). Conclusions: This prospective randomized trial observed 22% and 41% overall perioperative transfusion rates in patients treated by RARC and ORC, respectively, confirming a significant benefit in favor of RARC with intracorporeal UD. However, perioperative complications, hospital stay and 6-month health-related quality of life were largely comparable between groups. Oncologic and functional outcomes will be assessed at longer followup to observe potential differences between arms. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00225347
Volume :
207
Issue :
5
Database :
Supplemental Index
Journal :
Journal of Urology
Publication Type :
Academic Journal
Accession number :
156669528
Full Text :
https://doi.org/10.1097/JU.0000000000002422